AKTX: Akari Therapeutics Company Short-Term Debt
Akari Therapeutics (AKTX) develops proprietary molecules to combat severe autoimmune inflammation. The issuer's revenues rely on the therapy of rare orphan pathologies via government insurance. On GURU.Markets, the company's current liabilities visualize short-term debt, where 0.00 forms the current metric value. The brand's high authority within the scientific community confirms the promising nature of investments in these developments.
Metric breakdowns and analytics for Akari Therapeutics, Plc (AKTX)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Akari Therapeutics|AKTX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Akari Therapeutics|AKTX - Company Total Debt|Debt to Book Capitalization Ratio Akari Therapeutics Plc|AKTX - Company Long-Term Liabilities|Company Current Liabilities Akari Therapeutics|Quick Liquidity akaritx.com
- net income and valuation multiples indicators:
Initial company analysis:AKTX - Akari Therapeutics Plc
Developing innovative proteins to combat rare autoimmune pathologies requires significant funding, making liquidity control critically important for Akari Therapeutics (AKTX). By analyzing short-term financial liabilities on GURU.Markets, an investor assesses the volume of obligations maturing within one year to determine the risk of a cash crunch or the efficiency of capital management relative to the issuer's market capitalization.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|Upstream Bio Corp - Company Short-Term Debts|ZBIO - Company Short-Term Debts|Immunome, Inc. (IMNM) - Company Short-Term Debt|gossamerbio.com (GOSS) - Company Short-Term Debts|KALV (KalVista Pharmaceuticals, Inc.) - Company Short-Term Debts|Company Short-Term Debts Septerna, Inc.|Company Short-Term Debt Pieris Pharmaceuticals Inc (PVLA)|SVRA (Savara Pharma) - Company Short-Term Loans and Borrowings|Company Short-Term Debts RIGL (Rigel Pharmaceuticals)|Short-Term Debt Volume anaptysbio.com (ANAB)|ATXS: Company Current Liabilities|Company Short-Term Loans and Borrowings ENGN (enGene Holdings Inc)|RAPT (RAPT Therapeutics) - Company Current Liabilities|JBIO: Amount of Current Liabilities|ACRS (Aclaris Therapeutics) - Company Short-Term Debts|KYTX: Company Short-Term Loans and Borrowings|Company Short-Term Debts TLSA|CABA - Short-Term Debt|Company Short-Term Debt Ventyx Bio VTYX|Company Short-Term Loans and Borrowings THTX|Avalo Therapeutics, Inc - Company Short-Term Debts|ELDN - Company Short-Term Debts|Agenus Inc. (AGEN) - Company Short-Term Debt|Current Liabilities CLYM (Climb Bio Inc.)|ZURA (Zura Bio) - Company Short-Term Debts|Short-Term Debt aTyr Pharmaceuticals ATYR|Company Current Liabilities ADAG (Adagene)|Company Short-Term Debts ikenaoncology.com (IMA)|Shattuck Labs - Company Current Liabilities|Amount of Current Liabilities EQ (Equillium Inc)|Connect Pharma - Company Short-Term Debts|Short-Term Debt Volume Immunic, Inc. IMUX|ATRA: Company Short-Term Debts|Company Current Liabilities InflaRx|Company Short-Term Debt X4 Pharmaceuticals, Inc.|Adicet (ACET) - Short-Term Debt Volume|Company Short-Term Debts CELU|Company Short-Term Debts INmune Bio Corporation (INMB)|Company Short-Term Debt Barinthus Biotherapeutics BRNS|Company Short-Term Debts kezarlifesciences.com KZR|SABS: Company Current Liabilities|Enlivex Therapeutics - Amount of Current Liabilities|QTTB (q32bio.com) - Company Current Liabilities|Company Short-Term Indebtedness GOVX|Company Short-Term Debt Edesa Biotech, Inc.|ibioinc.com - Current Liabilities|Company Short-Term Debts CARM|XTLB (XTL Biopharmaceuticals Ltd) - Company Short-Term Loans and Borrowings|Company Short-Term Debts BOLT (Bolt Biotherapeutics, Inc.)|Company Short-Term Debts HCW Biologics, Inc. HCWB|APVO - Company Short-Term Debt|Company Short-Term Loans and Borrowings AIM (aimimmuno.com)|aditxt.com (ADTX) - Company Short-Term Debt|Company Current Liabilities GRI Bio Inc|XRTX (XORTX) - Company Short-Term Debts|Company Short-Term Debts Vyome Therapeutics|Company Current Liabilities REVB (Revelation Biosciences)|INDP (indaptusrx.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts SCNI (Scinai Immunotherapeutics Ltd.)|Short-Term Debt Volume CalciMedica Inc (CALI)|AFMD - Company Short-Term Debt|Allakos Inc. (ALLK) - Company Current Liabilities|hookipapharma.com (HOOK) - Company Short-Term Debt|Company Current Liabilities IGM Biosciences|Company Current Liabilities ITOS|Company Short-Term Debts Ocean Biomedical Inc|Company Short-Term Debt TC BioPharm (Holdings) PLC (TCBP)|Third Harmonic Bio Inc - Company Short-Term Indebtedness